Human medicines European public assessment report (EPAR): PritorPlus, telmisartan,hydrochlorothiazide, Date of authorisation: 22/04/2002, Revision: 39, Status: Withdrawn

Human medicines European public assessment report (EPAR): Aumseqa, Aumolertinib, Date of authorisation: 12/02/2026, Status: Revoked

Human medicines European public assessment report (EPAR): Aimovig, erenumab, Date of authorisation: 26/07/2018, Revision: 15, Status: Authorised

Annex to 15-18 September 2025 CHMP minutes

Minutes of the CHMP meeting 15-18 September 2025

Human medicines European public assessment report (EPAR): Hexacima, diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus influenzae type b conjugate vaccine (adsorbed), Date of authorisation: 17/04/2013, Date of refusal: 22/02/2013, Revision: 37, Status: Authorised

PSUSA/00011084/202603

Human medicines European public assessment report (EPAR): Hexyon, diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus influenzae type b conjugate vaccine (adsorbed), Date of authorisation: 17/04/2013, Date of refusal: 22/02/2013, Revision: 38, Status: Authorised

Human medicines European public assessment report (EPAR): Opdualag, relatlimab,nivolumab, Date of authorisation: 15/09/2022, Revision: 10, Status: Authorised

PSUSA/00000110/202601